TI
TRIL

Trexquant Investment’s Trillium Therapeutics Inc. TRIL Stock Holding History

Trexquant Investment’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-18,672
Closed -$181K – 1635
2021
Q2 		$181K Buy
18,672
+8,169
+78% +$76.9K 0.02% 936
2021
Q1 		$113K Sell
10,503
-1,905
-15% -$23.6K 0.01% 1044
2020
Q4 		$183K Buy
+12,408
New +$179K 0.02% 908
2017
Q1 		– Sell
-14,902
Closed -$84K – 1407
2016
Q4 		$84K Buy
+14,902
New +$148K 0.01% 911

Other funds holding TRIL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
OPU
Omni Partners US Irvine, California $1.95B AUM
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Trexquant Investment's TRIL Position: Q3 2021 in Review

Trexquant Investment sold out of Trillium Therapeutics Inc. (TRIL) in Q3 2021, closing a stake of 18,672 shares — an estimated $181K sold.

Trexquant Investment first reported a position in TRIL in Q4 2016 and held it in 4 quarters. The position peaked at $183K in Q4 2020. 181 funds tracked by Wall St. Rank hold TRIL as of Q3 2021.

  • Trexquant Investment reported no remaining Trillium Therapeutics Inc. position as of Q3 2021 after selling out during the quarter.
  • Trexquant Investment sold 18,672 Trillium Therapeutics Inc. shares in Q3 2021, an estimated $181K.
  • Trexquant Investment first reported a position in Trillium Therapeutics Inc. in Q4 2016 and held it in 4 quarters.
  • Trexquant Investment's Trillium Therapeutics Inc. position peaked at $183K in Q4 2020.
  • 181 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q3 2021.

Based on Trexquant Investment's 13F filing for Q3 2021, filed 12 Nov 2021.